RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        A review of the immunomodulatory activities of polysaccharides isolated from Panax species

        Yeye Hu,Yang He,Zhiqiang Niu,Ting Shen,Ji Zhang,Xinfeng Wang,Weicheng Hu a,Jae Youl Cho 고려인삼학회 2022 Journal of Ginseng Research Vol.46 No.1

        Panax polysaccharides are biopolymers that are isolated and purified from the roots, stems, leaves, flowers, and fruits of Panax L. plants, which have attracted considerable attention because of their immunomodulatory activities. In this paper, the composition and structural characteristics of purified polysaccharides are reviewed. Moreover, the immunomodulatory activities of polysaccharides are described both in vivo and in vitro. In vitro, Panax polysaccharides exert immunomodulatory functions mainly by activating macrophages, dendritic cells, and the complement system. In vivo, Panax polysaccharides can increase the immune organ indices and stimulate lymphocytes. In addition, this paper also discusses the membrane receptors and various signalling pathways of immune cells. Panax polysaccharides have many beneficial therapeutic effects, including enhancing or activating the immune response, and may be helpful in treating cancer, sepsis, osteoporosis, and other conditions. Panax polysaccharides have the potential for use in the development of novel therapeutic agents or adjuvants with beneficial immunomodulatory properties.

      • KCI등재

        The potential of Panax notoginseng against COVID-19 infection

        Yeye Hu,Ziliang He,Wei Zhang,Zhiqiang Niu,Yanting Wang,Ji Zhang,Ting Shen,Hong Cheng,Weicheng Hu 고려인삼학회 2023 Journal of Ginseng Research Vol.47 No.5

        The COVID-19 pandemic has changed the world and has presented the scientific community with unprecedentedchallenges. Infection is associated with overproduction of proinflammatory cytokines secondaryto hyperactivation of the innate immune response, inducing a cytokine storm and triggeringmultiorgan failure and significant morbidity/mortality. No specific treatment is yet available. For thousandsof years, Panax notoginseng has been used to treat various infectious diseases. Experimental evidenceof P. notoginseng utility in terms of alleviating the cytokine storm, especially the cascade, andimproving post-COVID-19 symptoms, suggests that P. notoginseng may serve as a valuable adjuncttreatment for COVID-19 infection.

      • SCIESCOPUSKCI등재

        Ginsenoside F2 enhances glucose metabolism by modulating insulin signal transduction in human hepatocarcinoma cells

        Shengqiang Han,Long You,Yeye Hu,Tingwu Liu,Jae Youl Cho,Weicheng Hu,Shuai Wei The Korean Society of Ginseng 2023 Journal of Ginseng Research Vol.47 No.3

        Background: Ginsenoside F2 (GF2), a minor component of Panax ginseng, has been reported to possess a wide variety of pharmacological activities. However, its effects on glucose metabolism have not yet been reported. Here, we investigated the underlying signaling pathways involved in its effects on hepatic glucose. Methods: HepG2 cells were used to establish insulin-resistant (IR) model and treated with GF2. Cell viability and glucose uptake-related genes were also examined by real-time PCR and immunoblots. Results: Cell viability assays showed that GF2 up to 50 μM did not affect normal and IR-HepG2 cell viability. GF2 reduced oxidative stress by inhibiting phosphorylation of the mitogen-activated protein kinases (MAPK) signaling components such as c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase 1/2 (ERK1/2), and p38 MAPK, and reducing the nuclear translocation of NF-κB. Furthermore, GF2 activated PI3K/AKT signaling, upregulated the levels of glucose transporter 2 (GLUT-2) and GLUT-4 in IR-HepG2 cells, and promoted glucose absorption. At the same time, GF2 reduced phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression as well as inhibiting gluconeogenesis. Conclusion: Overall, GF2 improved glucose metabolism disorders by reducing cellular oxidative stress in IR-HepG2 cells via MAPK signaling, participating in the PI3K/AKT/GSK-3β signaling pathway, promoting glycogen synthesis, and inhibiting gluconeogenesis.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼